-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 LCfOThBhxMevoD7iopjviL3BKFrfKax2ckhF7rFNV9otMdImhqUSupjD+UPEL6Fn
 +5n4/M2gNUPOVY7nXMQETw==

<SEC-DOCUMENT>0001096906-08-001235.txt : 20080902
<SEC-HEADER>0001096906-08-001235.hdr.sgml : 20080901
<ACCEPTANCE-DATETIME>20080625133341
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001096906-08-001235
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20080625

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UTAH MEDICAL PRODUCTS INC
		CENTRAL INDEX KEY:			0000706698
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				870342734
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		7043 S 300 WEST
		CITY:			MIDVALE
		STATE:			UT
		ZIP:			84047
		BUSINESS PHONE:		8015661200
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<html>
  <head>
    <title>utahmedcorr062508.htm</title>
<!-- Licensed to: a-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">
    <div>
      <hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
      <hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
    </div>
    <div>&#160;</div>
    <div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><img src="utahmedicalproductslogo.jpg" alt=""></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">June 25,
2008</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">David
Burton, Staff Accountant</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Division
of Corporation Finance</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">U.S.
Securities and Exchange Commission</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Washington,
D.C. 20549-0306</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">VIA
FACSIMILE [202-772-9218] and U.S. Certified Mail</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Re: Utah
Medical Products, Inc.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Form 10-K
for the year ended December 31, 2007</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Form 10-Q
for the quarter ended March 31, 2008</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">File No.
001-12575</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Dear Mr.
Burton:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Thank you
for your review of Utah Medical Products, Inc.&#8217;s (UTMD&#8217;s) recent SEC Form 10-K
and 10-Q filings.&#160;&#160;This is UTMD&#8217;s requested response to the SEC
comments, which will also be filed on EDGAR as private correspondence with the
SEC.&#160;&#160;I have incorporated the SEC comments received June 16, 2008 in
italics followed by UTMD&#8217;s responses.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Form 10-K for the year ended
December 31, 2007</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 7. Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations, page
15</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top">
              <td style="WIDTH: 18pt">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">1.</font></div>
              </td>
              <td>
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We
      do not see where you have provided the information required by Item
      303(A)(4) of Regulation S-K. Please tell us if you have any off-balance
      sheet arrangements that have or are reasonably likely to have a current or
      future effect on your financial condition, changes in financial condition,
      revenues or expenses, results of operations, liquidity, capital
      expenditures or capital resources. Revise future filings to include the
      disclosures required by Item 303(A)(4) of Regulation
  S-K.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD Response to Item
1</font>:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">UTMD does not have any off-balance
sheet arrangements that have or are reasonably likely to have a current or
future effect on its financial condition, changes in financial condition,
revenues or expenses.</font>&#160;&#160;&#160;UTMD will revise future filings to
include the disclosures required by Item 303(A)(4) of Regulation S-K, or the
preceding statement.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top">
              <td style="WIDTH: 18pt">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">2.</font></div>
              </td>
              <td>
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We
      see your disclosure of contractual obligations in Note 7 to the
      consolidated financial statements. Please revise future filings to also
      include disclosure of the information required by Item 303(A)(5) of
      Regulation S-K within Item 7 of the Form
10-K.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD Response to Item
2</font>:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">UTMD will
revise future filings to also include in MD&amp;A the table in Note 7 of the
consolidated financial statements, which provides the disclosures required by
Item 303(A)(5) of regulation S-K.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Notes to Consolidated
Financial Statements, page 32</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Note 15 &#8212; Recent Accounting
Pronouncements, page 42</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><br>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;
</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
      </div><br>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top">
              <td style="WIDTH: 18pt">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">3.</font></div>
              </td>
              <td>
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We
      note your disclosure here that you recognize interest accrued related to
      unrecognized tax benefits in operating expenses. Please tell us how your
      accounting policy complies with paragraph 19 of FIN 48, or alternatively
      revise future filings to comply with paragraph 19 of FIN
    48.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD Response to Item
3</font>:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">In
paragraph 2 of Note 15 of the financial statements, the statement that UTMD
&#8220;recognizes interest accrued related to unrecognized tax benefits along with
penalties in operating expenses&#8221; was an incorrect statement of UTMD&#8217;s accounting
policy.&#160;&#160;UTMD will correct this statement in future filings to
disclose that such interest expenses are included in interest expense, in
compliance with paragraph 19 of FIN 48.&#160;&#160;UTMD will further note that
its accounting policy is to include any penalties in income taxes, in compliance
with paragraph 19 of FIN 48.&#160;&#160;As Note 15 further discloses, UTMD did
not have any accrued or actual interest expense or penalties related to
underpayment of taxes in the reporting periods covered by the referenced SEC
Form 10-K and SEC 10-Q.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibits 19 and
20</font></font></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top">
              <td style="WIDTH: 18pt">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">4.</font></div>
              </td>
              <td>
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We
      note that the identification of the certifying individual at the beginning
      of the certification required by Exchange Act Rule 13a-14(a) also includes
      the title of the certifying individual. Please revise the certifications
      in future filings to remove the certifying individual&#8217;s title at the
      beginning of the certification.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD Response to Item
4</font>:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">UTMD will
revise the certifications in future filings to remove the certifying
individual&#8217;s title at the beginning of the certification, in compliance with
Exchange Act Rule 13a-14(a).</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Form 10-Q as of March 31,
2008</font></font></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top">
              <td style="WIDTH: 18pt">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">5.</font></div>
              </td>
              <td>
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We
      note your significant available-for-sale securities at March 31, 2008.
      However, we do not see where you have included any disclosures relating to
      the adoption of SFAS 157. Please confirm to us that you adopted SFAS 157
      on January 1, 2008 and provide us with the disclosures required by
      paragraphs 32-35 of SFAS 157. In addition, please also revise future
      filings to include these disclosures. If you did not adopt SFAS 157,
      please tell us why you determined you were not required to adopt SFAS 157
      on January 1, 2008. Refer to SFAS 157 and FSP
  157-2.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD Response to Item
5</font>:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">UTMD
adopted SFAS 157 on January 1, 2008.&#160;&#160;Please find below a table of
available-for-sale securities (in thousands).&#160;&#160;&#160;&#160;UTMD will
ensure that future filings include the disclosures required by paragraphs 32-35
of SFAS 157.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div align="left">
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td valign="bottom" width="32%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" valign="bottom" width="15%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="10" valign="bottom" width="49%" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Fair
      Value Measurements at Reporting Date Using</font></div>
              </td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td valign="bottom" width="32%" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Description</font></font></div>
              </td>
              <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">3/31/2008</font></font></div>
              </td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Quoted
      Prices in Active Markets for Identical Assets</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(Level 1)</font></font></div>
              </td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Significant
      Other Observable Inputs</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(Level 2)</font></font></div>
              </td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Significant
      Unobservable Inputs</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(Level 3 )</font></font></div>
              </td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr bgcolor="#cceeff">
              <td align="left" valign="bottom" width="32%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Available-for-sale
      securities</font></div>
              </td>
              <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">$</font></td>
              <td align="right" valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">21,139</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">$</font></td>
              <td align="right" valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">21,139</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">$</font></td>
              <td align="right" valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">0</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">$</font></td>
              <td align="right" valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">0</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">In
connection with responding to our comments, please provide, in writing, a
statement from the company acknowledging that:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">&#183;&#160;&#160;the
company is responsible for the adequacy and accuracy of the disclosure in the
filing;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD
Response</font>:&#160;&#160;UTMD understands that the Company is responsible for
the adequacy and accuracy of the disclosure in the filing.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;
</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
      </div><br>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">&#183;
staff comments or changes to disclosure in response to staff comments do not
foreclose the Commission from taking any action with respect to the
filing;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Response</font>:&#160;&#160;UTMD
understands that staff comments or changes to disclosure in response to staff
comments do not foreclose the Commission from taking any action with respect to
the filing.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&#183; <font style="DISPLAY: inline; FONT-STYLE: italic">and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any
person under the federal securities laws of the United
States.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Response</font>:&#160;&#160;This
last statement is somewhat confusing, as UTMD clearly relies on SEC staff
comments to represent what it needs to do to satisfy SEC disclosure
requirements.&#160;&#160;Consistent with prior responses to SEC comments, UTMD
is unwilling to acknowledge this last statement, as we believe it may also
represent a violation of UTMD&#8217;s Constitutional rights.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Thank you
for your review of the referenced disclosures.&#160;&#160;I hope that the above
responses are complete and to the satisfaction of the SEC.&#160;&#160;If not,
please give us the opportunity to augment the responses as needed.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Sincerely,</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">/s/ Kevin
L. Cornwell</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Kevin L.
Cornwell</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Chairman
&amp; CEO</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Direct
tele no. (801) 569-4190</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Direct
fax no. (801) 566-1328</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
        <hr style="COLOR: black" noshade size="2">
      </div>
    </div>
  </body>
</html>


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>utahmedicalproductslogo.jpg
<TEXT>
begin 644 utahmedicalproductslogo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@```#$!`@`0````3@``````
M``!@`````0```&`````!````4&%I;G0N3D54('8T+C`P`/_;`$,``@$!`0$!
M`@$!`0("`@("!`,"`@("!00$`P0&!08&!@4&!@8'"0@&!PD'!@8("P@)"@H*
M"@H&"`L,"PH,"0H*"O_;`$,!`@("`@("!0,#!0H'!@<*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"O_``!$(`&``
M50,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/T$^%7@3X(^._\`@G%\)OVE/$7[,7PFD\7^--3\$Q:[J(^&6DA9
M?[4\0:=979$?D;5+0W,H!Q\I((Y%<=X6^"GP>^#WQ>^/]_\`%GPYX-\5^'O@
MP-&BT/0-0^$7A.T_MZZU+28Y8;>::VTN-UD:]GBCB*,@&Y0X89)9X7_:P_8W
M^#7PR\#>++SP3\>K;X8:]J<WB7X5_#S4_P#A'YM*DOK;6[6,1VXAN3=QK!>7
ML5U%!>7"V\8C!C`,,4:^I7'Q<_9;3]IGQ)-/\,OB6GQ:U;XMZ/#<_#*:?3F?
M5]3LO#AEL[@-%<O:BQAL)%O7=[A3'-;Q$J)3%%(`>)?#SXB_`&;X3_!63QE^
MR?\`"K7/%D'[0NH?#/XR1>"_@U8WAU0VOAW7+^&[L[9+=I(X[I;;2M0&T92*
M=E.%#5[A\!/`W[*'QI_;?^)WP=A_8G\%:9X7\)_##P?JNF6'B3X*VFF71O\`
M4-1\2174RBXM4DDA:+3[-5.-H:*0#G=69\:/&_[)?PN_:U7XS?%;X4_$?3/B
MK%XP\&WMCX)TR_T]X-<O+PZAX3T[5K<M<+!(@&MRVMP7FCD18;5GB`6$R=EX
MI_;`_9Y^`W[3WB3X@?%GX/\`Q%\)_$3Q/X>\%^'4T?51ILZZOI#^)I-+LKRT
M-I>S0[+?4?$N+G?*LRQS1,(F!3>`<CX@MOV-OAO^W;J_P4^*G[(/P;TKX;3>
M#X8]$\57/@338EMO$MK!<ZG?V=P[0X`ETIX;F+G@:==D]5S\\KXM^'7Q1^.>
M@?#'7OV8/"GPXM+SXC>+]+U&Q\%_`33-;UF"QM-&T34]*26W?2[MHY3!JJ//
MB(A'<H'VJI/UW^VC;_L1_#75+CP;^TQX&UOQ/-\3/%UCXUTK1X8%N3>:YI5Q
MX=TBRL+1`Z,))Y9[!!$<Q.DEX9I$B9@>&^.'PNT#X;^//&_[=6N_L[?'CPQK
MFB-=>+=5UCP=XC\)W")$^@VMA>-%#>794LMGHEHLB;6;>R&)G#/L`.2^&?[*
M'AWXQCX_ZUX9T;X=:1J/PO\`B'/H'A#3=5^"GAE](N(H/#VD:@K:A']@2[)D
MGO9O,,=S#M4@*%*\^6?L_?&'X6?M8_%GP+\+?"7['?PD\)Q?%J+P_JUI>S?"
MW2KB;PQI4O@RWUV^A@WV^R>ZDN)XXHI)E=$1GD,;[`A]V\!Q_#?XF^*/%'PL
M\+_#_P"/2I\5;+3/'7Q)\%3^(?#5H;W3=4@ATF/4'N+:Y-PJ31::XDAM;E'5
M;28E$,L23];^UQ\+_P!C']E_5]/^(?B3PWXPTC6==UB76/"FK>`FMHIO#5SX
M>\)WK_Z(LI6..-]*L+BV,#K+#*9@DB!&+*`<K^V'^S7\(_V4OV<=7TWX=_##
MX4>*/B-XJU.2U^&U]X\^%F@016DJ6C7,B7)LK*&-XPMM.%D,0Q)/!&V<[BW]
MFW_ACK]IG]ICP4/AY^RE\+$\!>,?V=K?QS9V$OPVTL75MJ$FII`T<C^1N5XE
M+1/'QMD1LC(KTSP/\=/V8/#?@SPM^W1X@^/'BWQ9IFLV^H:+;^(/%'V6`>'(
MVC^U:C'=6L,%L+)X3HXCGC,?F1R6[*R;C(3QO[-'[-_@G4/B)I?QY^!7P[^-
M?@'2/'5IJUWIVNOJ6@BWL]/U.^?6Y(I+&X\ZXL8)[J1Y8T2/SHVN"D@@Y50#
M[9HHHH`_*^W^"O[(.F?\$XK3]G*_^/7PMF^*T46GV.H:[?\`C*6XCM[2+Q';
M:E=6MM/*&>UB>.W!,4*QHTD:9&5##5^'MO\`!+X"_%OPSXP^&?[2WPFU72_A
M9XPUJ^\&MJ7BT0ZAXBT37+)8[VTU&?RG9M0M)H+;R+V0RFZMX4CF9)"\]?IO
M7D?[;'[<G[-7_!/?X$:C^T/^U%\08="T*R_=6D"+YEYJET5)2TM(00TTSX.%
M&`H!9V5%9@`?$/[6VO?#O]IOXTZ-^U5'^T+\++#5O!NJ>$(?"'@N?QP@:33[
M'Q7INO:K-=W2Q,B3S#3;>&&)!(B"$LTI,Q6*U^U?>_"[]LCQJ/CQXG_:@^$'
MACQ%X.T+3+?X9^&5\:O>6\UU;>)M&\0W$FHW2VZ&%9I="LK4+#'-Y2-++ND9
MQ$GY._MB_P#!WW_P4H^+/Q@N]9_9&U'1_A3X(MRT6DZ+)X>L=6OKF//$]W/=
MPR+YI'\$*HB@[?G(WGRC_B*F_P""X?\`T=MIW_AM]!_^0J`/W-_:9^)7P[_:
MZ\:^"?C]>?M!?"?P9XG^$=W;ZEX"\/7_`(Z%[;ZK?'4K"ZO(KZ>&#_1X'AT]
M+>*2-)71KAYFC/EK$_K/Q>_;:^#W[1'[,OQ0^$VL?%3X;>%[_P`3_#[4M&T`
M3_$**[,E[=65Q"?.\N$+%`KO%M<,[N&<F./:`_G/_!M+^WE^U#_P42_X)^:U
M\=OVMOB##XE\3V?Q/U'1[?4(-%M+$+9Q65A*D?EVL4:$AYY3N*[CNP3@#$7_
M``<R?MT_M3?\$]O^">^B_'+]D/XG#PGXIN_BAIVD7&IG1+*_WV<ME?RR1>7>
M0RQC+P1'<%W#;@$`D$`S?C[XA_9P^+/A/X=^#=(^*GPJTSQ7X)\)Z%:^&OC7
MI?Q'>RUCPQ>03)]OC5(85DN+1HH8BD!D,5R[.DR1*!(>Q_X*)_%#]G?]J?2?
M"5E\-/VJ?AO$^AQ>*UO/[4\3+$"=1\)ZQI-OMVJV<7-]`6Z80.PR0%/\^_\`
MQ%(_\%TO^CVX_P#PVGAK_P"5U>J_L?\`_!W;_P`%0_@[\7+77OVJO%>E?%[P
M;.RQ:KX?N?#>FZ1=0Q[OFEM+BPMHMLH':99$(XPI.\`'ZV?MM?!_]C_]HOQ3
M,OPF_;I\"^%?"OQ&MKZQ^-_AEM51H=0DFT.]TV'7+$`XBU%!<)%+G"7,*H7(
M>",M[3X!_P""CM[X9^%VC^#]5\0?!35/$^CV%M9ZA?1?%PVNG:FR;(C/;`6$
MDL>Y0TABD1?+/R!Y?OGV+]@O_@H+^R]_P4B^!5I\?OV7/'J:KILA6+5M*N@L
M6H:+=;<M:WD`8F*0=B"4<?,C.I#'VN@"2BBB@#A/VD_VB?A/^R7\"/%/[1_Q
MR\3)I'A3PAI,FH:Q>L,ML7`6.-?XY9'*QH@Y=W51R:_C>_X*P_\`!4[X\?\`
M!5S]IR^^-GQ2OI]/\.6$DMMX"\%1W):UT#3RPP@'`>>3:K338R[``;42-$_3
M[_@\Y_X*'ZIK'Q`\'_\`!-7X?:XR:;HUI%XI^(:P2_Z^\E#+86CXYQ'%ON"I
MR&-S`W6,5^$-`!17::K^S]\5-"^`>C_M,:UX:DM?!_B'Q+=Z%H6I3G;]NO+6
M&*6Y$:_Q)&L\0+]-S[1DJ^WBZ`/ZCO\`@S*_Y1/>)/\`LMFK_P#IMTJE_P"#
MS/\`Y1.^'?\`LM>D?^F[5*3_`(,RO^43WB3_`++9J_\`Z;=*I?\`@\S_`.43
MOAW_`++7I'_INU2@#^7"BBNO\/\`P)^*'BKX)^)?VAO#WAF6[\*>#]<TS2?$
MFHP_-]@N-02Z>T,BCD(_V.==_P!T/L4G+J"`>M?\$Q_^"E?[0'_!+?\`:;TS
M]H3X(:J\]FSI;>+_``I/<,MGXAT[=E[:8#(#@$M'+@M$^&&1N5O[*/V1_P!J
MCX0?ML?LY>$_VH?@5KOV_P`,^+]*2\LF?`EMGR5EMIE!(2:*57B=<G#HV"1@
MG^$ZOW"_X,S/^"@^J^"OCIXL_P""<GCK7G?1/&=E-XC\#03R9%OJUM&/MD$8
M[>=:KYI'0&R)'+G(!_1U1110!_$+_P`%7/V@M0_:E_X*2_&WXYWU\UQ%K/Q&
MU*/3)&;)&GVTQM;-<_[-M#"O_`:\.\'^$]>\>^+M*\#>%;!KK5-:U&"PTVU3
MK-/-(L<:#W+,!^-4[^^N]4OIM2OYC)/<2M+-(W5G8DDGZDU]#?\`!(70M+\2
M?\%4OV<]'UK8;:3XU^&FD2095]FI0.$([ABH7\:`/U$_X.J?V5?`O[$/_!.O
M]CW]E/X<V\:Z9X);6;!IXTV_;+G[-9/<W3#^_-.TLS?[4AK\,*_HD_X/@X96
M^#'[/DZQ,47Q1KZLX7@$VUF0"?4X/Y&OYVZ`/ZCO^#,K_E$]XD_[+9J__IMT
MJE_X/,_^43OAW_LM>D?^F[5*H?\`!E[XET'4?^"7GC+PQ9ZK#)J&F_&C49+Z
MS5QYD*2Z;IAB=EZA6V.`>A,;#^$TG_!Z'XJ\/Z9_P2_\&>$[W5(DU+5?C/IT
MEA9EQYDL<.FZD99`O4JOF1@GL9$'<4`?S`5^WO\`P:5_LQ?#S]L_]DC]M+]E
MKXIVBRZ)XWT?PMIMQ(8P[6LC1ZT8;E`>/,AF6.9#V>-37XA5_03_`,&-UK<)
MX<_:7O6B(BDO?"*))V+*FL%A^`9?SH`_!/XH_#KQ/\'_`(F>(OA)XWL_L^M>
M%M=N](U>W!_U5U;3/#*OX.C#\*]3_P"":7Q^O_V6_P#@H'\&_CY97A@C\-_$
M72I]096QOL7N$BNX\]@]O)*A]FKN_P#@N3I&DZ)_P5\_:)L]%C587^*>IW#A
M""/-ED\V4\=S([D^]?*L<DD,BRQ2,KJP*LIP01T(-`']_=%5-!N9KW0[*\N7
MW236D;R-C&6*@DT4`?PN_ML?!R^_9Y_;%^*GP*U&T,,GA#XAZQI*H1C*07LL
M:,/56158'N"#6'^SC\8-1_9Z_:&\!_'W1X&EN_`_C/2_$%K$K8+R6=W%<*H/
M;)C`K]/O^#P/]A;4O@'_`,%`[']KOPWHS+X8^,VCQRW=Q%'B.#7+&*.WN(CC
MA?,@%K,">7=YCSM)K\CJ`/ZM_P#@YD_9DMO^"BG_``1SA^/WP!`U^;P3)8_$
M/P[-8(7;4=%>U<7)CQU7[+<"YQU(M@!R<'^4BOZ%_P#@U$_X+5^"]?\`A[I_
M_!*K]JCQ3;VFJZ>TD7PCU?590(=4M)&+-HSL_'G(S,8`>)(V\H8,<:OY%_P7
M,_X-8OBW\-_'FM_M3?\`!,SP%-XG\%ZI<27NM?"W28]VI:#*Q+/_`&?$.;JU
M)SMA3,L60JK(@R@!^57[%W_!07]L7_@GIX]N_B1^Q]\<]4\&ZCJ4"0:K%;PP
MW-IJ$:DE%N+6X22&;;N;:S(63>VTKDTG[:/_``4#_;#_`."A?C^T^)?[8/QQ
MU/QEJ6G6[0:5'<0PVUKI\3$%E@MK=(X8=Q5=Q5`S[5W%L"O)_$/AWQ!X2UNZ
M\,^*]"O-,U*QF:&]T_4+5X9[>0=4>-P&1AW!`-1Z3I&JZ_J=OHFA:9<7M[=R
MK%:VEI"TDLTC'"HB*"68G@`#)H`KU_4]_P`&KO[,$7[#/_!)+5?VG?CCMT%O
MB+?77C34+J_7R_L7A^VM@EM+)_L&**>Z![QW*FOSW_X(B_\`!K1\=/V@?'>B
M_M'_`/!1KP#?^"?AKI\Z7EGX!U>-H-8\3%2&2.>$X>RM2?O^9MF=0555#B4?
M1_\`P=7_`/!9?P!\,OA#=_\`!*#]E#Q!9MK6J6\5K\4+O12JP:%I:!2FC)Y>
M`LTNU!*@XCA7RR,RD(`?@[^UO\=K[]J#]J;XC_M(:C`\4OCSQSJNO>1)UA6[
MNY)UBXSC8KA0/1:9^RA\'-0_:(_:A^'/P$TNU::?QIXYTK1$C49_X^KN*$D^
M@`<DGL`37G]?J_\`\&A_[#.H?M&?\%&9/VH?$.CM)X6^"VDO?B>2,F.;6KM)
M+>SB]"50W-QD?=:WCR/F%`']3O3I1110!\U_\%7/^"=/P]_X*A_L6^)OV7/&
M<\%CJ=PHU'P9X@EB+_V/K,*M]GN,#DH=SQ2`<F*:0#!((_C*_:%_9^^+G[*_
MQJ\1_L^?';P;=:!XL\*ZD]EK&F72\HZ\JZ-TDC=2KI(N5='5E)#`U_>+7P/_
M`,%NO^"$7P1_X*W_``]C\6:/>6GA#XQ>'[`P^%_&WV<F*\B&66PU!4&Z2W+$
ME9`#)"S%E#`O&X!_('9WEWIUY%J&GW4D%Q!(LD$\+E7C=3E65AR""`01TK^Q
M;_@WJ\9_MU_$K_@F'X(^)?[>_C5M=U[7P]WX2N[^T*:FWA\JBV<E]+G_`$B:
M0*TJR$!VBDB+L[EC7X$?\$\/^#?']K#X@_\`!6'1/V,OVR_@GJ_AKP[X7+>(
MO'5_+&39:GHMM*@VV=TG[N=;F5HH`T;;D$DC$!HF4?UG:9IFG:+IMOH^CV$-
MI:6D"0VMK;1!(X8U`5415P%4```#@`4`<3\7OV5_V8?V@I$E^/?[.'@+QNT:
M;(V\7^#[+4BJ^@^T1/@>U1_"+]DG]E3]GZ[:_P#@-^S+\/O!$[*5:;PCX,L=
M-<J>H)MXD.*]!HH`^-/^"^'BW]N?X>?\$R?'WQ(_8#\:?V'XK\/6XO\`Q!=6
MEEYNH?V$BL+UK%R<07$:$3>;@L(X9-FV0HP_C9U/4]2UO4KC6=9U">[O+N=Y
MKN[NI6DEFE=BS.[,268DDDDY).:_OMN[2TU"TEL+^UCG@GC:.:&9`R2(1@JP
M/!!!((/6OY-_^"I?_!OU^U)\)O\`@JGJ'[+?[%GP'UOQ3X8\?%O$/P\;3K8_
M9=-TZ64K-;W-PV(K9+68F+?*X_=F!B<R@$`_/SX)?!7XH?M&_%KP_P#`SX+>
M#KOQ!XJ\4ZG%I^B:18IF2XF<X')X50,LSL0J*K,Q"J2/[,/^"0?_``39\$?\
M$LOV)?#O[-6@3VU_X@D)U7QYK\$>!JFLS*OG.I(!\J-52&/(!\N%"1N+9\._
MX(7?\$"?A'_P2<\%-\3?B%>:?XP^->NV/E:UXIB@)MM&@8`M8Z=O`94)XDG(
15Y<#A%PE?HA0!)1110!__]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
